Abstract
Anxiety disorders tend to be highly prevalent in heart disease, particularly amongst patients recovering from acute cardiac events. Yet, the role of anxiety in heart disease has not received as much attention in the literature as has depression. Epidemiologic studies indicate that there is an increased risk of sudden death and myocardial infarction in patients experiencing panic anxiety. Pathophysiologic correlates of anxiety appear to contribute to an increased cardiac risk, leading to the appreciation that anxiety disorders might in fact constitute a risk to life as exemplified by the cardiovascular disease link. Explanatory mechanisms of cardiac risk point to a link between anxiety and heart disease being mediated by stress giving way to increased cardiac sensitivity and reactivity.
The present chapter reviews the psychobiological link between anxiety and heart disease. It also supports an integrative approach for the analysis of psychogenic heart disease, that cardiac patients can benefit from cardiologists educating them about the influence of psychosocial factors on their cardiac conditions and that further research is required on the development of specific psychologically based therapies which tap into the proposed pathophysiological mechanisms associated with the mind-heart nexus.
References
AHF. (2014). Heart disease and stroke statistics – 2014 update: A report from the American Heart Association. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Dallas, Texas, United States.
Ahn, J. H., Park, S. H., Shin, W. Y., & Lee, H. M. J. Y. (2011). Long QT syndrome and Torsade de Pointes associated with Takotsubo cardiomyopathy. Journal of Korean Medical Sciences., 26, 959–961.
Albert, C. M., Chae, C. U., Rexrode, K. M., Manson, J. E., & Kawachi, I. (2005). Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation, 111, 480–487.
Alvarenga, M. E., Richards, J. C., Lambert, G., & Esler, M. D. (2006). Psychophysiological mechanisms in panic disorder: A correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability and psychological variables. Psychosomatic Medicine, 68, 8–16.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association (text rev.).
Asmundson, G. J., Sandler, L. S., Wilson, K. G., & Norton, G. R. (1993). Panic attacks and interoceptive acuity for cardiac sensations. Behaviour Research and Therapy, 31(2), 193–197.
Atiga, W. L., Calkins, H., Lawrence, J. H., Tomaselli, G. F., Smith, J. M., & Berger, R. D. (1998). Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. Journal of Cardiovascular Electrophysiology, 9, 899–908.
Atiga, W. L., Fananapazir, L., McAreavey, D., Calkins, H., & Berger, R. D. (2000). Temporal repolarization lability in hypertrophic cardiomyopathy caused by β-myosin heavy-chain gene mutations. Circulation, 101, 1237–1242.
Barlow, D. H. (2002). Anxiety and its disorders. The nature and treatment of anxiety and panic (2nd ed.). New York: Guilford Press.
Batelaan, N. M., ten Have, M., van Balkom, A. J. L. M., Tuithof, M., & de Graff, R. (2014). Anxiety disorders and onset of cardiovascular disease: The differential impact of panic, phobias and worry. Journal of Anxiety Disorders, 28, 252–258.
Berger, R. D., Kasper, E. K., Baughman, K. L., Marban, E., Calkins, H., & Tomaselli, G. F. (1997). Beat to beat QT internal variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation, 96, 1557–1565.
Bers, D. M. (2002). Cardiac excitation contraction coupling. Nature, 415, 198–205.
Bigger, J. T., Fleiss, J. L., Steinman, R. C., Rolnitzky, L. M., Kleiger, R. E., & Rottman, J. N. (1992). Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation, 85(1), 164–171.
Black, P. H., & Garbutt, L. D. (2002). Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research, 52(1), 1–23.
Brennan, A. M., Fargnolli, J. L., Li, T., Williams, C. J., Willett, W., Kawachi, I., Qi, L., Hu, F. B., & Mantzoros, C. S. (2009). Phobic anxiety is associated with higher serum concentrations of adipokines and cytokines in women with diabetes. Diabetes Care, 32(5), 926–931.
Brosschot, J. F., Van Dijk, E. & Thayer, J. F. (2007). Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep period. International Journal of Psychophysiology 63, 39–47.
Brunner, L. S., Suddarth, D. S., & O’Connell Smeltzer, S. C. (2004). Brunner & Suddarth’s textbook of medical-surgical nursing. Philadelphia: Lippincott Williams & Wilkins.
Bunker, S. J., Colquhoun, D. M., Esler, M. D., Hickie, I. B., Hunt, D., Jelinek, V. W., Oldenburg, B. F., Peach, H. G., Ruth, D., Tennant, C. C., & Tonkin, A. M. (2003). “Stress” and coronary heart disease: Psychosocial risk factors. Medical Journal of Australia, 178(6), 272–276.
Cameron, O. G. (2007). Understanding comorbid depression and anxiety. Psychiatric Times, 24(14), 51–56.
Chiou, A., Potempa, K., & Buschmann, M. B. (1997). Anxiety, depression and coping methods of hospitalized patients with myocardial infarction in Taiwan. International Journal of Nursing Studies, 34(4), 305–311.
Coryell, W., Noyes, R., & House, D. (1986). Mortality among outpatients with anxiety disorders. American Journal of Psychiatry, 143(4), 508–510.
Coughlin, S. S. (2011). Posttraumatic stress disorder and cardiovascular disease. The Open Cardiovascular Medicine Journal, 5, 164–179.
Crotti, L., Celano, G., Dagradi, F., & Schwartz, P. J. (2008). Congenital long QT syndrome. Orphanet Journal of Rare Diseases, 3, 18.
Da Costa, J. M. (1871). Art. 1. On irritable heart; a clinical study of a form of functional cardiac disorder and its consequences. American Journal of Medical Sciences, 121(1), 2–52.
Daly, J., Sindone, A. P., Thompson, D. R., Hancock, K., Chang, E., & Davidson, P. (2002). Barriers to participation in and adherence to cardiac rehabilitation programs: A critical literature review. Progress in Cardiovascular Nursing, 17(1), 8–17.
Delmas, C., Lairez, O., Mulin, E., Delmas, T., Boudou, N., Dumonteil, N., Biendel-Picquet, C., Roncalli, J., Elbaz, M., Galinier, M., & Carrie, D. (2013). Anxiodepressive disorders and chronic psychological stress are associated with Tako-Tsubo cardiomyopathy- new physiopathological hypothesis. Circulation Journal, 77(1), 175–180.
Descartes, R. (1649). Le Passiones de L’Alme (passions of the soul) (trans: Voss, S. H.). Indianapolis: Hackett, 1989.
El-Gabalawy, R., Mackenzie, C. S., Thibodeau, M. A., Asmund, G. L., & Sareen, J. (2013). Health anxiety disorders in older adults: Conceptualizing complex conditions in late life. Clinical Psychology Review, 33(8), 1096–1105.
Esler, M. D. (1998). Mental stress, panic disorder and the heart. Stress Medicine, 14, 237–243.
Esler, M. (2000). The sympathetic system and hypertension. American Journal of Hypertension, 13(2), 99S–105S.
Esler, M., Alvarenga, M., Kaye, D., Lambert, G., Thompson, J., Hastings, J., Schwarz, R., Morris, M., & Richards, J. (2004a). Panic disorder. In D. Robertson, P. A. Low, G. Burnstock, & I. Biaggioni (Eds.), Primer of the autonomic nervous system. Amsterdam: Elsevier.
Esler, M., Alvarenga, M., Lambert, G., Kaye, D., Hastings, J., Jennings, G., Morris, M., Schwarz, R., & Richards, J. (2004b). Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Annals of the New York Academy of Science, 1018, 505–514.
Esler, M., Alvarenga, M., Pier, C., Richards, J., El-Osta, A., Barton, D., Haikerwal, D., Kaye, D., Schlaich, M., Guo, L., Jennings, G., Socratous, F., & Lambert, G. (2006). The neuronal noradrenaline transporter, anxiety and cardiovascular disease. Journal of Psychopharmacology, 20(4), 60–66.
Esler, M., Schwarz, R., & Alvarenga, M. (2008). Mental stress is a cause of cardiovascular diseases: From scepticism to certainty. Stress and Health, 24, 175–180.
Fleet, R., Lavoie, K., & Beitman, B. D. (2000). Is panic disorder associated with coronary artery disease? A critical review of the literature. Journal of Psychosomatic Research, 48, 347–356.
Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., & Ferrari, R. (2008). Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet, 6372(9641), 817–821.
Frasure-Smith, N., Lesperance, F., & Talajic, M. (1995). The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression? Health Psychology, 14(5), 388–398.
Friedman, S. (2000). Cardiac disease, anxiety and sexual functioning. American Journal of Cardiology, 86(2 Suppl 1), 46–50.
Gold, L. S., Kane, L. B., Sotoodehnia, N., & Rea, T. (2007). Disaster events and the risk of sudden cardiac death: A Washington State investigation. Prehospital Disaster Medicine, 22(4), 313–317.
Goldstein, D. S., Robertson, D., Esler, M. D., Straus, S., & Eisenhofer, G. (2002). Dysautonomias: Clinical disorders of the autonomic nervous system. Annals of Internal Medicine, 137(9), 753–763.
Gomez-Caminero, A., Blumentals, W. A., Russo, L. J., Brown, R. R., & Castilla-Puentes, R. (2005). Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosomatic Medicine, 67(5), 688–691.
Grace, S. L., Abbey, S. E., Irvine, J., Shnek, Z. M., & Stewart, D. E. (2004). Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychotherapy and Psychosomatics, 73(6), 344–352.
Graham, H. (2003). A conceptual map for studying long-term exercise in a cardiac population. Rehabilitation Nursing, 28(3), 80–86.
Haines, A. P., Imeson, J. D., & Mease, T. W. (1987). Phobic anxiety and ischaemic heart disease. British Medical Journal, 295, 297–299.
Hammel, J. C., Smitherman, T. A., McGlynn, D., Mulfinger, A. M. M., Lazarte, A., & Gothard, K. D. (2011). Vagal influence during worry and cognitive challenge. Anxiety, Stress and Coping: An International Journal, 24(2), 121–136.
Heidenreich, W. F. (2003). Assessment for congenital long QT syndrome. Journal of Insur Med, 35(3–4), 196–200.
Heikkila, J., Paunonen, M., Laippala, P., & Virtanen, V. (1998). Nurses’ ability to perceive patients’ fears related to coronary arteriography. Journal of Advanced Nursing, 28(6), 1225–1235.
Herrmann, C., Brand-Driehorst, S., Buss, U., & Rüger, U. (2000). Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. Journal of Psychosomatic Research, 48(4–5), 455–462.
James, W. (1892). The stream of consciousness (Psychology). Cleveland/New York: H.Holt, Chapter XI.
Janszky, I. S., Ahnve, S., Lundber, I., & Hemmingsson, T. (2010). Early onset depression, anxiety, and risk of subsequent coronary heart disease: 37 year follow up of 49,321 young Swedish Men. Journal of American Cardiology, 56(1), 31–37.
Kalisch, R., Wiech, K., Critchley, H. D., Seymour, B., O’Doherty, J. P., Oakley, D. A., Allen, P., & Dolan, R. J. (2005). Anxiety reduction through detachment: Subjective, physiological, and neural effects. Journal of Cognitive Neuroscience, 17(6), 874–883.
Kannel, W. B., Cupples, L. A., & D’Agostino, R. B. (1987). Sudden death risk in overt coronary heart disease: The Framingham study. American Heart Journal, 113(3), 799–804.
Kawachi, I., Sparrow, D., Vokonas, P. S., & Weiss, S. T. (1994). Symptoms of anxiety and risk of coronary heart disease: The normative aging study. Circulation, 90, 2225–2229.
Kawachi, I., Colditz, G. A., Ascherio, A., Rimm, E. B., Giovannucci, E., Stampfer, M. J., & Willett, W. C. (1996). A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. Journal of Epidemiology & Community Health, 50(3), 245–5.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, R., & Walters, E. E. (2005). Lifetime prevalence of age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602.
Khoury, N., Marvar, P. J., Gillespie, C. F., Wingo, A., Schwartz, A., Bradley, B., Kramer, M., & Ressler, K. J. (2012). The renin-angiotensin pathway in PTSD: ACE inhibitor and ARB medications are associated with fewer traumatic stress symptoms. Journal of Clinical Psychiatry, 73(6), 849–855.
Kircanski, K., Craske, M. G., Epstein, A. M., & Wittchen, H. U. (2009). Subtypes of panic attacks: A critical review of the empirical literature. Depression and Anxiety, 26, 878–887.
Kolloch, R., Legler, U. F., Champion, A., Cooper-Dehoff, R. M., Handberg, E., et al. (2008). Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: Findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). European Heart Journal, 29, 1327–1334.
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., & Keil, U. (2009). Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II and III surveys in eight European countries. The Lancet, 373(9667), 929–940.
Kubzansky, L. D., & Arthur, C. M. (2004). Anxiety, heart disease and mortality. In N. Anderson (Ed.), Emotional longevity. New York: Viking.
Kubzansky, L. D., Kawachi, I., Spiro, A., III, Weiss, S. T., Vokonas, P. T., & Sparrow, D. (1997). Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the normative aging study. Circulation, 95(4), 818–824.
Lambert, E., Hotchkin, E., Alvarenga, M., Pier, C., Richards, J., Barton, D., Dawood, T., Esler, M., & Lambert, G. (2006). Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. Journal of Physiology, 570(3), 637–643.
Lane, D., Carroll, D., Ring, C., Beevers, D. G., & Lip, G. Y. (2001). Predictors of attendance at cardiac rehabilitation after myocardial infarction. Journal of Psychosomatic Research, 51, 497–501.
Lane, R. D., Laukes, C., Marcus, F. I., et al. (2005). Psychological stress preceding idiopathic ventricular fibrillation. Psychosomatic Medicine, 67, 359–365.
Leor, J., Poole, W. K., & Kloner, R. A. (1996). Sudden cardiac death triggered by an earthquake. The New England Journal of Medicine, 334, 413–419.
Malik, M., & Camm, A. J. (1990). Heart rate variability. Clinical Cardiology, 13, 570–576.
Malliani, A., Pagani, M., Lombardi, E., & Cerruti, S. (1991). Cardiovascular neural regulation explored in the frequency domain. Circulation, 84, 482–492.
Mansour, V. M., Wilkinson, D. J. C., Jennings, G. L., Schwarz, R. G., Thompson, J. M., & Esler, M. D. (1998). Panic disorder: Coronary spasm as a basis for cardiac risk? MJA, 168, 390–392.
Martens, E., De Jonge, P., Na, B., Cohen, B., Lett, H., & Whooley, M. (2010). Scared to death? Generalised anxiety disorder and cardiovascular events in patients with stable coronary heart disease. Archives of General Psychiatry, 67(7), 750–758.
Mathers, C. D., & Loncar, D. (2006). Updated projections of global mortality and burden of disease, 2002–2030: Data sources, methods and results. PLoS Med, 3(11):e442. Text available at http://www.who.int/healthinfo/statistics/bod_projections2030_paper.pdf
Matthews, K. A., Owens, J. F., Kuller, L. H., Sutton-Tyrrell, Lasilla, H. C., & Wolfson, S. K. (1998). Stress-induced pulse pressure changes predicts women’s carotid atherosclerosis. Stroke, 29, 1525–1530.
Mayou, R. A., Gill, D., Thompson, D. R., et al. (2000). Depression and anxiety as predictors of outcome after myocardial infarction. Psychosomatic Medicine, 62(2), 212–219.
McGrady, A., McGinnis, R., Badenhop, D., Bentle, M., & Rajput, M. (2009). Effects of depression and anxiety on adherence to cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation & Prevention., 29(6), 358–364.
Meisel, S. R., Kutz, I., Dayan, K. I., Pauzner, H., Chetboun, I., Arbel, Y., & David, D. (1991). Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet, 338(8768), 660–661.
Mendenhall, M. E., Osland, J. S., Bird, A., Oddou, G. R., & Maznevski, M. L. (2008). Global leadership: Research, practice, and development. London: Routledge.
Molgaard, H., Sorensen, K. E., & Bjerregaard, P. (1991). Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clinical Autonomic Research, 1, 233–237.
Moser, D. K., & De Jong, M. J. (2006). Anxiety and heart disease. In E. Mollinari, A. Compare, & G. Paratti (Eds.), Clinical psychology and heart disease. Italia: Springer.
Moser, D. K., & Dracup, K. (1996). Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosomatic Medicine, 58, 395–401.
Mosovich, S. A., Boone, R. T., Reichenberg, A., Bansilal, S., Shaffer, J., Dahlman, K., Harvey, P. D., & Farkouh, M. E. (2008). New insights into the link between cardiovascular disease and depression. International Journal of Clinical Practice, 62, 423–432.
Nesbitt, W. S., Giuliano, S., Kulkarni, S., Dopheide, S. M., Harper, I. S., & Jackson, S. P. (2003). Intercellular calcium communication. The Journal of Cell Biology, 160(7), 1151–1161.
Pajak, A., Jankowski, P., Kotseva, K., Heidrich, J., De Smedt, D., & De Bacquer, D. (2013). Depression, anxiety and risk factor control in patients after hospitalisation for coronary heart disease: The EUROASPIRE III study. European Journal of Cardiology, 20(2), 331–340.
Paterniti, S., Zureik, M., Ducimetière, P., Touboul, P. J., Fève, J. M., & Alpérovitch, A. (2001). Sustained anxiety and 4-year progression of carotid atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 136–141.
Phillips, A. C., Batty, G. D., Gale, C. R., Deary, I. J., Osborn, D., MacIntyre, K., & Carroll, D. (2009). Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: The Vietnam experience study. Psychosomatic Medicine, 71(4), 395–403.
Pieper, S., Brosschot, J. F., van der Leeden, R., & Thayer, J. F. (2007). Cardiac effects of momentary assessed worry episodes and stressful events. Psychosomatic Medicine, 69, 901–909.
Purvis, J. A., Cunningham, E. L., McGlinchey, P. G., & Barr, S. H. (2009). Drugs, electrolytes and takotsubo cardiomyopathy: Triple aetiology of acquired long QT syndrome and torsades de pointes. Ulster Medical Journal, 78(3), 188–189.
Radhakrishna, R. K. A., & Yeragani, V. K. (2001). Decreased chaos and increased non-linearity of heart rate time series in patients with panic disorder. Autonomic Neurosciences, 88, 99–108.
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. (1986). Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behaviour Research & Therapy, 24(1), 1–8.
Ridker, P. M. (2007). C-reactive protein and the prediction of cardiovascular events amongst those at intermediate risk: Moving an inflammatory hypothesis toward consensus. Journal of the American College of Cardiology, 49(21), 2129–2138.
Roest, A. M., Martens, E. J., De Jonge, P., & Denollet, J. (2010). Anxiety and risk of incident of coronary heart disease: A meta-analysis. Journal of the American College of Cardiology, 56(1), 38–46.
Rosengren, S., Hawkin, S., Ounpuu, S., et al. (2004). Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): Case–control study. Lancet, 364, 953–962.
Rothenbacher, D., Hahmann, H., Wusten, B., Koenig, W., & Brenner, H. (2007). Symptoms of anxiety and depression in patients with stable coronary heart disease: Prognostic value and consideration of pathogenic links. European Journal Cardiovascular Preven Rehabiliation, 14(4), 547–554.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99, 2199–2217.
Saavedra, J., Sanchez-Lemus, E., & Benicky, J. (2011). Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology, 36(1), 1–18.
Sovari, A. A., Cesario, D., Kocheril, A. G., & Brugada, R. (2008). Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm. Journal of Interventional Cardiology and Electrophysiology, 21(3), 223–226.
Steptoe, A., Wikman, A., Molloy, G. J., Messerli-Burgy, N., & Kaski, J. C. (2013). Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease. Brain, Behaviour & Immunity, 31, 183–188.
Thomsen, S. B., Rathke, C. N., Zerahn, B., & Vestergaard, H. (2010). Increased levels of calcification marker matrix GIa protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. Cardiovascular Diabetology, 9, 86.
Thornton, E. W., Bundred, P., Tytherleigh, M., & Davies, A. D. M. (2006). Anxiety, depression and myocardial infarction: A survey of their impact on consultation rates before and after an acute primary episode. British Journal of Cardiology, 13(3), 220–224.
Thrall, G., Lip, G. Y. H. P., Carroll, D., & Lane, D. (2007). Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest, 132(4), 1259–1264.
Thurston, R. C., Rewak, M., & Kubzansky, L. D. (2013). An anxious heart: Anxiety and the onset of cardiovascular diseases. Progress in Cardiovascular Diseases, 55(6), 524–537.
Uzun, S., Vural, H., Uzun, M., & Yokusoglu, M. (2008). State and trait anxiety levels before coronary angiography. Journal of Clinical Nursing, 17(5), 602–607.
Walters, K., Rait, G., Petersen, I., & Williams, R. (2008). Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: Cohort study using the general practice research database. European Heart Journal, 29(24), 2981–2988.
Wilbert-Lampen, U., Leistner, D., Greven, S., Pohl, T., Sper, S., Völker, C., Güthlin, D., Plasse, A., Knez, A., Küchenhoff, H., & Steinbeck, G. (2008). Cardiovascular events during World Cup soccer. New England Journal of Medicine, 358, 475–483.
Wilkinson, D. J., Thompson, J. M., Lambert, G. W., Jennings, G. L., Schwarz, R. G., Jefferys, D., Turner, A. G., & Esler, M. D. (1998). Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Archives of General Psychiatry, 55(6), 511–520.
Wulsin, L. R., & Singal, B. M. (2003). Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine, 65, 201–210.
Yeragani, V. K., Pohl, R., Berger, R., Balon, R., Ramesh, C., Glitz, D., Srinivasan, K., & Weinberg, P. (1993). Decreased heart rate variability in panic disorder patients: A study of power spectral analysis of heart rate. Psychiatry Research, 46(1), 89–103.
Yeragani, V. K., Pohl, R., Jampala, V. C., Balon, R. R., & Srinivasan, K. (2000). Increased QT variability in patients with panic disorder and depression. Psychiatry Research, 1093(3), 225–235.
Zafar, M. U., Paz-Yepes, M., Shimbo, D., Vilahur, G., Burg, M. M., Chaplin, W., Fuster, V., Davidson, K. W., & Badimon, J. J. (2010). Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. European Heart Journal, 31(13), 1573–1582.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Singapore
About this entry
Cite this entry
Alvarenga, M.E., Byrne, D. (2015). Anxiety and Cardiovascular Disease: Epidemiology and Proposed Mechanisms. In: Alvarenga, M., Byrne, D. (eds) Handbook of Psychocardiology. Springer, Singapore. https://doi.org/10.1007/978-981-4560-53-5_10-1
Download citation
DOI: https://doi.org/10.1007/978-981-4560-53-5_10-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Online ISBN: 978-981-4560-53-5
eBook Packages: Springer Reference Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences